ANR — Anatara Lifesciences Share News
0.000.00%
Last trade - 00:00- AU$3.14m
- AU$2.05m
Brief: Anatara Lifesciences Receives Firm Commitments For A$1.2M Placement
Brief: Anatara Lifesciences Seeks Trading Halt
Brief: Anatara Lifesciences Says Hong Kong Patent Granted For GARP Product
Brief: Anatara Lifesciences Seeks Trading Halt Pending Announcement Regarding Update On Phase II Garp-Ibs Trial
Brief: Anatara Lifesciences Says Australian Patent Granted For GARP Product
Brief: Anatara Lifesciences Seeks Trading Halt
Brief: Anatara Lifesciences Says European Patent Granted For GARP Product
Australia's Anatara Lifesciences hits 1-month high on patent grant
Australia's Anatara Lifesciences falls on discounted placement
Brief: Anatara Lifesciences Says Got Firm Commitments For A$1.0 Million In A Placement
Brief: Anatara Lifesciences Ltd Seeks Trading Halt
Brief: Anatara Lifesciences Launches Partially Underwritten A$1.055 Mln Entitlement Offer
Australia's Anatara Lifesciences hits record low on discounted placement
Brief: Anatara Lifesciences Seeks Trading Halt
Brief: Anatara Lifesciences Seeks Trading Halt
Brief: Anatara Lifesciences Seeks Trading Halt
Brief: Anatara Lifesciences Receives Firm Commitments For About A$0.865mln In Successful Placement
Brief: Anatara Lifesciences Seeks Trading Halt Pending Announcement In Relation To Capital Raising
Brief: Anatara Lifesciences Says Announce Resignation Of Its CEO, Steven Lydeamore